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ABSTRACT
Cardiopulmonary exercise testing (CPET) has become an 
invaluable tool in healthcare, improving the diagnosis of 
disease and the quality, efficacy, assessment and safety of 
treatment across a range of pathologies. CPET’s superior 
ability to measure the global exercise response of the 
respiratory, cardiovascular and skeletal muscle systems 
simultaneously in a time and cost- efficient manner has 
led to the application of CPET in a range of settings from 
diagnosis of disease to preoperative assessment. The 
Association for Respiratory Technology and Physiology 
Statement on Cardiopulmonary Exercise Testing 2021 
provides the practitioner and scientist with an outstanding 
resource to support and enhance practice, from equipment 
to testing to leadership, helping them deliver a quality 
assured service for the benefit of all patient groups.
INTRODUCTION
Initially used in sports and exercise science 
to determine aerobic and anaerobic fitness 
thresholds in athletes, cardiopulmonary exer-
cise testing (CPET) is increasingly being used 
in the healthcare setting and has been used in 
preoperative medicine for over 20 years. CPET 
is used for diagnostic assessment of patients 
presenting with dyspnoea of unknown origin, 
assessment of respiratory or cardiovascular 
disease or for presurgical assessment prior to 
major elective surgery.
Patients are often poor at estimating their 
own cardiopulmonary fitness. This can lead 
to difficulty in identifying the cause of exer-
cise intolerance during clinician assessment. 
Pulmonary function testing can be considered 
as a weak predictor of disability and quality of 
life in patients with chronic respiratory condi-
tions,1 while traditional static tests of cardiac 
function have been shown to correlate poorly 
with physical fitness.2
Field exercise tests, such as 6 min walk tests, 
are repeatable, reproducible and sensitive to 
therapeutic intervention3 but crucially lack 
the information required to precisely deter-
mine aerobic capacity. Dynamic assessments, 
such as dobutamine stress echocardiography, 
do not allow for objective measurement of 
functional capacity.4 Treadmill- based stress 
electrocardiography provides an indirect 
assessment of functional capacity but has 
been shown to be poorly tolerated by elderly 
patients and have a negative predictive 
value for postoperative outcomes in elective 
surgical patients.5
The benefit of performing CPET is that it 
is a relatively non- invasive objective test which 
provides a direct objective measurement of 
the global exercise responses of the respi-
ratory, cardiovascular and skeletal muscle 
systems during incremental exercise. Analysis 
of the integrative exercise responses of these 
body systems can offer a wealth of informa-
tion when compared with traditional indi-
vidual diagnostic tests performed at rest.
Since 2008, the number of departments 
in the NHS performing CPET has increased 
by 40%, and over 15 000 CPETs are now 
performed annually in the UK.6 Within UK 
respiratory departments, the number of CPET 
increased by 81% between 2005 and 2015 
with an estimated annual increase of 8% per 
year.7 CPET is routinely performed on both 
adult and paediatric patients, in respiratory 
or cardiology laboratories, and is increasingly 
being performed in anaesthetic departments 
or presurgical assessment units.
The interpretation and clinical value of 
CPET relies on a series of interventions 
before, during and after the act of measure-
ment. In recent years, this has become 
increasingly important. CPET is no longer 
Key messages
 ► This statement outlines the latest best practice guid-
ance for the performance of cardiopulmonary exer-
cise testing (CPET) within a healthcare environment.
 ► Recommendations are provided on how to under-
take CPET safely, to quality assured standards and 
using the most suitable reference values available 
for the interpretation of results.
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just a diagnostic tool to assess patients with suspected 
cardiovascular and respiratory disease. The quantifi-
cation of risk prior to major surgery can now be deter-
mined more confidently. A decision to proceed to major 
surgery or the level of care required postoperatively can 
be supported by gas exchange data recorded during 
CPET. Modern, commercially available exercise testing 
systems require less and less awareness from the end user 
on potential sources of error. These systems are often 
more complex, and the risk of introducing systematic 
bias into measurement is higher. CPET is complex; the 
integrative nature of the information allows scrutinising 
the onset of unexplained symptoms on exertion that no 
other investigation is capable of.
The aim of this document was to provide compre-
hensive guidance for performing CPET in the clinical 
setting, offering a standardised approach to CPET based 
on current scientific knowledge and best practice. The 
document offers recommendations around specific indi-
cations for CPET, test protocol selection, testing equip-
ment, appropriate personnel, and patient and test safety. 
The intended audience for this document is those health-
care professionals who plan to, or currently, perform 
CPET in the clinical setting.
This document is a consensus statement from experts 
in the field and is supported by previously published liter-
ature. The Association for Respiratory Technology and 
Physiology (ARTP) CPET working party group consists 
of respiratory physiologists and clinical scientists with a 
wide range of clinical experience in cardiopulmonary 
exercise testing (CPET) in adult and paediatric patients, 
clinical research in the field of exercise physiology, CPET 
service development, preoperative evaluation of surgical 
patients and exercise prescription.
GENERAL PROCEDURES
Indications
CPET has a wide range of indications in a clinical setting 
(box 1), evaluating exercise tolerance, assessment of 
surgical risk, identifying specific pathophysiology and 
monitoring their progression and/or response to treat-
ment. Although it can provide large amounts of detailed 
data, it should be used as a supplementary assessment 
when questions remain after baseline clinical examina-
tions, including routine pulmonary function testing, to 
fine- tune a diagnosis or reveal abnormalities that are not 
distinguishable on resting measurements.
Risk stratification
CPET is generally a safe procedure (box 2), more so in 
patients with no pre- existing comorbidity. Various studies 
place complication rates at 2–5 per 100 000 tests.8 9 Recent 
UK data have reported no serious adverse events from 
4983 tests during pulmonary assessment and an occur-
rence of a patient safety incident in 2 per 1000 tests.10 It is 
important to remember that CPET is a symptom limited 
and often maximal effort test; hence, there is some risk 
of inducing syncope, exercise- induced hypoxaemia and 
malignant cardiac dysrhythmias, and exacerbating previ-
ously latent conditions. Thorough pretest preparation 
and adherence to safety recommendations will help to 
mitigate these risks significantly.
Previously published guidance8 11 12 have described 
certain clinical conditions in which CPET is contra-
indicated, either as an absolute, and so the test is not 
performed, or relative, where the test is recommended 
to be conducted under medical supervision. In line 
with more recent publications,13 14 we recommend an 
approach that considers and balances risk versus benefit 
of undertaking a CPET. As with any test, clinical CPET 
should only be undertaken if the results will alter patient 
management. Accordingly, if the risk of performing a 
CPET is felt to be high, then it may be appropriate to 
ensure there are adequate measures in place to mitigate 
the risk; however, if not sufficient, then it may be advis-
able to consider an alternative diagnostic modality, in 
place of CPET.
We have outlined in figure 1 a tool for assessing the 
risk associated with performing CPET in various clinical 
scenarios. The healthcare environment in which the 
procedure is being performed, the specialist support 
that is available etc. should also be taken into consider-
ation. Risk assessment is likely to be different if a CPET 
is conducted in a specialist heart and lung centre where 
specialist assistance is available for complex cardiorespi-
ratory conditions or whether the assessment is performed 
in a non- specialist setting.
As an example, clarity has often been sought by 
those involved in CPET testing regarding the safety of 
performing maximal effort exercise testing in patients 
Box 1 Indications for performing cardiopulmonary exercise 
testing
Indications
 ► Investigation of unexplained dyspnoea.
 ► Evaluation of cardiovascular disease.
 ► Evaluation of respiratory disease.
 ► Preoperative assessment for major surgery.
 ► Exercise prescription.
 ► Evaluation of impairment/disability.
 ► Evaluation of exercise tolerance.
Adapted from the American Thoracic Society and American College of Chest 
Physicians.8
Box 2 Known risk of adverse events associated with 
performing cardiopulmonary exercise testing
Risk of adverse events
 ► Incidence of a complication requiring hospitalisation of ≤2 in 1000.
 ► Incidence of a major cardiac event of 1.2 per 10 000.
 ► Incidence of mortality of 2–5 per 100 000.
Adapted from Levett et al.11
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with abdominal aortic aneurysm (AAA). The combina-
tion of exercise and aneurysms raises theoretical concerns 
regarding the risk of expansion and rupture; however, the 
published evidence available suggests that performing 
exercise stress testing in a hospital setting is safe and pres-
ents a low incidence of acute adverse events.15–19 There is 
one published case study of an abdominal aortic dissec-
tion following cardiopulmonary testing.20
A conservative approach should be taken for those 
undergoing CPET for preoperative assessment of AAA. 
Cardiovascular exercise is generally regarded as safe in 
the absence of hypertension,21 but there are currently no 
published data on what would constitute an excessively 
hypertensive response during cardiovascular exercise in 
the presence of aneurysms. The consensus opinion of the 
authors of this document is that CPET should be discon-
tinued if blood pressure exceeds 200 mm Hg systolic or 
110 mm Hg diastolic. Although maximal effort symptom 
limited exercise testing provides a full assessment of func-
tional capacity, in the presurgical assessment of patients 
with AAA, consideration should be given to performing 
a submaximal test, terminating the test as soon as there 
Figure 1 Tool for assessing the risk associated with performing CPET in various clinical scenarios. AAA, abdominal aortic 
aneurysm; CPET, cardiopulmonary exercise testing.
4 Pritchard A, et al. BMJ Open Resp Res 2021;8:e001121. doi:10.1136/bmjresp-2021-001121
Open access
is confirmation that anaerobic threshold has been 
achieved.
Consent
Consent is the principle that a person must give permis-
sion before they receive any type of medical treatment, 
test or examination. Consent is an essential component 
of both medical ethics and human rights law. Consent is 
only valid if it is voluntary and informed. Importantly, the 
person giving consent must have the capacity to make the 
decision.
Any patient attending for CPET should therefore be 
provided with all relevant information about the test 
process, the risks and benefits of completing the investi-
gation, and implications of not performing the test. This 
information should be presented in lay terms (box 3) 
and provided in plenty of time ahead of the appointment 
date to allow the patient sufficient time to formulate and 
raise any queries.
Patients may also give non- verbal consent, as long as 
they understand the treatment or examination about to 
take place, for example, holding out an arm for a blood 
test, allowing the CPET mask to be fitted or taking up 
position on the cycle ergometer.
Our recommendation would be that formal written 
consent is obtained, that is, completion and signing of 
a consent form, prior to the investigation taking place if 
the CPET test will include invasive aspects of physiolog-
ical measurement, for example, measurement of arterial 
or capillary blood gas or laryngoscopy.
Consent should be given to the healthcare professional 
directly responsible for the person’s current tests or 
treatment. If the subjects change their mind at any point 
before the test commences or even during the test, the 
test must be stopped.
Children under the age of 16 years can provide 
consent if they are believed to have enough intelligence, 
competence and understanding to fully appreciate what 
is involved in their treatment. This is known as being 
‘Gillick competent’. If the child is not Gillick competent, 
then someone with ‘parental responsibility’ can provide 
consent for them. This could be the following:
 ► The child’s mother or father.
 ► The child’s legally appointed guardian.
 ► A person with a residence order concerning the child.
 ► A local authority designated to care for the child.
 ► A local authority or person with an emergency protec-
tion order for the child.
The person with parental responsibility must have the 
capacity to give consent.
Preparation
Before, during and after CPET, the practitioner must 
consider all aspects involved with the patient’s test. 
Some of these may have a direct or indirect impact on 
the test accuracy and patient experience. All clinical staff 
working in the exercise laboratory setting will have the 
responsibility to consider the standards set out further. 
This should ensure a good patient experience, reduce 
risk and eliminate any potential sources of bias.
General patient considerations
Practitioners should remain professional at all times, 
answer any patient questions honestly and avoid asking 
leading questions. Patients may have very specific 
needs that should be accommodated by the attending 
member of staff (where possible). This may be due to 
previous experiences and ethnic, religious or cultural 
background. Also consider disability: wheelchair users, 
deafness, blindness and patients with learning disabil-
ities. Interpreters should also be organised as neces-
sary. If the patient appears anxious or uncomfortable, 
anticipate their needs, be cordial and communicate 
clearly. Patients attending for presurgical assessment are 
likely to be extremely anxious ahead of potentially life- 
changing major surgery; recognition and anticipation 
of this is essential to ensure the patient is reassured as 
much as possible to promote successful test completion 
and to ensure the patient can perform optimally. Inter-
preters, chaperones, friends or relatives should accom-
pany the patient to the testing room (space permitting), 
with the patient’s consent. However, consideration for 
the patient’s dignity when undressing and during ECG 
preparation should be paramount.
Pretest instructions
Patients attending for a CPET should receive clear infor-
mation ahead of the appointment, which clearly outlines 
the test procedure and provides a rationale for why the 
test is required. Clear guidance on any special measures 
the patient is expected to take before attending should 
also be included (box 4).
Are there any permanent or temporary conditions that 
could affect their ability to move, bear weight, balance 
or walk? Is the patient pregnant? Obtaining this infor-
mation will ensure that valuable appointment slots are 
not wasted. The use of a wheelchair or walking aid does/
will not necessarily render CPET unfeasible. The patients 
will also need to be aware that if they feel unwell (eg, 
suffering from a chest infection, cold, etc), it will be a 
Box 3 Lay terminology for describing the risk of adverse 
events to patients attending for cardiopulmonary exercise 
testing testing
Lay terminology
 ► The risk of side effects is the same as performing mild exercise.
 ► The number of patients who develop complications during the test 
is low.
 ► Complications may include abnormal blood pressure, fainting or a 
change in heart rhythm.
 ► Extremely rare, serious complications such as heart attack or stroke 
may occur
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requirement to reschedule the appointment to ensure 
optimal effort can be invested into the test.
It is also important to ascertain information regarding 
the patient’s mobility prior to the test. Good practice 
is therefore to trial the patient on the cycle ergometer 
before preparing the patient for the ECG electrode place-
ment. Patients with severe end- stage arthritis undergoing 
preassessment for total hip replacement or knee replace-
ment are capable of maximal symptom limited exercise 
using ergometry methods.22 In practice, patients awaiting 
lower limb joint replacement often tolerate cycle ergom-
etry, with a slightly higher saddle position, reducing the 
required flexion at the knee.
Patients should be as relaxed as possible before the test 
and should be seated for 5–10 min prior to testing. The 
purpose and nature of the test should be clearly and fully 
explained to the patient,14 allowing opportunities for the 
patient to ask questions or to clarify any concerns.
INFECTION CONTROL
There is often a diverse range of patients attending for a 
CPET. Some patients may pose an infection risk, whereas 
others may themselves be vulnerable to a range of infec-
tions, creating potential risk of cross- infection. However, 
the degree of risk remains unknown with limited evidence 
available.
Cross- infection may occur either by direct patient 
contact or indirect contact, which is most likely when the 
patient comes into contact with contaminated surfaces, 
equipment or healthcare personnel, and inhalation of 
aerosol particles or droplets via airborne route through 
tubing, mouthpieces or masks.23
CPET has a raised potential for cross- infection and 
should be classed as a high- risk procedure due to the 
nature of increased levels of patient ventilation24 and 
greater capacity to generate aerosols. To combat this, 
consideration should be given to environmental ventila-
tion levels in the testing area. Negative pressure testing 
rooms, use of high efficiency particulate air (HEPA) filtra-
tion or rooms with higher (>12) air changes per hour 
(ACH) provide the lowest- risk environment. Rooms with 
ACH  of >6 but <12 provide a moderate risk environment, 
require regular cleaning and ‘fallow periods’ between 
patients. Testing environments with ACH  of <6 should 
be classed as the highest- risk testing environment.24
It is important for laboratories to practise appro-
priate routine cleaning and decontamination of all non- 
disposable consumables, equipment, work surfaces and 
personnel with local policies in place, including cleaning 
protocols, cleaning logs, practising good hand hygiene 
and appropriate use of personal protective equipment 
(PPE).
Historically, the use of PPE in respiratory laboratories 
has not been enforced, even though there are numerous 
respiratory infections that are transmitted via aerosol- 
generating procedures (AGPs), such as CPET. Therefore, 
PPE should be used in all AGP environments in accor-
dance with the type of infection and level of risk posed 
(table 1).
Cleaning and decontamination of all non- disposable 
consumables and equipment can be performed using 
multiple methods. An appropriate area for cleaning of 
non- disposable consumables should be identified; all 
cleaning and decontamination should only take place 
in this specific area. The use of chemicals should be in 
accordance with local control of substances hazardous 
to health (COSHH) policies, local infection control 
teams and manufacturer guidelines; some chemicals may 
cause unnecessary degrading of equipment. Clean items 
should be clearly labelled and stored in such a way as to 
avoid contamination.
Table 1 Recommended levels of PPE in relation to levels of infection risk
Level of risk Known infection Community prevalence Recommended PPE
Level 1 No known infection risk No pandemic Three- ply surgical mask, disposable 
apron, surgical gloves
Level 2 Upper respiratory tract infection, lower 
respiratory tract infection, influenza
Pandemic with low community 
prevalence
Face shield, three- ply surgical mask, 
disposable apron, surgical gloves
Level 3 Tuberculosis, family Coronaviridae, 
SARS, pandemic influenza
Global pandemic with high 
community prevalence
FFP3 mask with face shield or 
respirator hood, isolation gown, 
surgical gloves
PPE, personal protective equipment.
Box 4 Pretest patient instructions for issue to patients ahead 
of attending for cardiopulmonary exercise testing appointment
 ► Refrain from exercise on the day of the test and be well rested.
 ► Eat a light meal or breakfast no less than 2 hours hours previously.
 ► Maintain hydration by drinking water.
 ► Avoid caffeine and alcohol prior to the test.
 ► Take all routine/normal medication and bring along a medication 
list.
 ► Bring along all rescue medications, for example, inhalers or nitro-
lingual sprays.
 ► Wear light comfortable clothing and shoes suitable to exercise in.
 ► Avoid use of body lotion on the upper body, as this may affect ECG 
electrode placement.
 ► Abstain from smoking for at least 8 hours hours prior to the test.
 ► Refrain from wearing any nail varnish or false nails.
Adapted from the American Thoracic Society and American College of Chest 
Physicians.8
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With known infectious patients, additional measures 
may be considered such as employing the use of a 
bacterial viral filter to prevent aerosolisation of micro- 
organisms.25 The filters used in pulmonary function 
testing are not recommended for clinical exercise testing 
due to increased production of water vapour in exhaled 
breath at high ventilatory frequencies during vigorous 
exercise, saturating the filter. Increased water vapour is 
likely to impact on time to volitional fatigue, especially in 
those who are ventilatory capacity limited,26 and to reduce 
the effectiveness of the filter once excessively saturated, 
as well as impair the quality of the gas exchange data.
There is very limited evidence supporting the use 
of a filter during CPET. A recent study performed by 
University Hospital of Wales on a small cohort of healthy 
subjects suggested CPET can be performed effectively 
while employing a filter and reducing risk of transmitting 
aerosolised particles,27 but further research in the use of 
a bacterial viral filter during CPET is warranted.
No research has been conducted in elderly or respira-
tory compromised population; therefore, the impact of 
potential increased resistance posed to the respiratory 
effort in these populations is unknown and the use of 
filters cannot be recommended.
QUALITY ASSURANCE (QA)
QA describes the systematic processes used to ensure a 
clinical service meets quality standards. Good QA systems 
will use a robust series of checks before, during and after 
the patient’s visit to ensure that the results generated 
will be as accurate and precise as possible. The role of 
QA and quality control (QC) within the testing envi-
ronment is of immense value to ensure that those who 
perform the test can resolve arising issues in a proactive 
manner, providing accurate, meaningful information to 
the referring clinician, and ensure that the patients get 
the desired outcome as a result of performing the test, 
and the reported results are the best possible representa-
tion of the clinical status of the patient. In clinical and 
research settings, QA and QC have different purposes. 
QA can be defined as a group of routines and interven-
tions to ensure the data recorded are of high quality, 
while QC is the process of measuring and monitoring the 
quality of the data.28
Our recommendation is that any department 
performing CPET should subscribe to an appropriate 
and recognised accreditation scheme as a quality marker, 
enabling demonstration of compliance with governance 
standards. In the UK, physiological services should align 
with the Improving Quality in Physiological Services 
(IQIPS) programme.29
IQIPS is a systematic accreditation process delivered 
by United Kingdom Accreditation Service in the UK for 
physiological services, including cardiac, respiratory and 
sleep services. This involves provision of evidence that 
demonstrates services are compliant with the domains 
of the accreditation process. Accredited services are 
required to constantly monitor and review their delivery 
of patient care. IQIPS is recognised by the Care Quality 
Commission. IQIPS can also act as a service improve-
ment tool to highlight areas where services are below the 
required standard to facilitate service improvement.
QA and QC
Physiologists/scientists must give consideration to all 
‘sources of variation other than disease’.30 Any form 
of clinical measurement is highly complex, as there 
are numerous sources of variability inherent to the 
different processes required to record information. This 
tends to start with a referral and terminates with a set 
of numerical values and graphs. All test and non- test 
specific factors within these two landmarks need to be 
taken into account. This includes the laboratory envi-
ronment, the patient, the test operator, the equipment 
and test protocols. Common sources of error in CPET 
testing are documented in table 2. The next sections will 
detail considerations, routines and interventions within 
each of these factors that are expected to be part of the 
QA programme, including QC methods to measure and 
monitor data accuracy and precision.
Test operator
A well- constructed and well- adhered to QA programme 
is founded on enthusiastic and motivated staff. The role 
of the healthcare professional involved in the prepara-
tion, monitoring, evaluation and interpretation of CPET 
is vital to ensure the data recorded are a good representa-
tion of the patient’s exercise capacity and that meaningful 
information is given to the referring clinician. There is a 
clear degree of crossover between cardiac and respiratory 
physiology that needs to be well understood by test opera-
tors to take advantage of, fully comprehend and translate 
into a clear description of the integrative nature of CPET.
Staff involved in equipment maintenance and calibra-
tion must be familiar with the advantages and caveats 
of different methods of measurement, as well as tech-
nical concepts as this allows higher standards in QA and 
monitoring.
Audit and feedback
There are a series of aspects before, during and after 
CPET that altogether may contribute to bias in meas-
urement, almost like a ‘snowball effect’. The process by 
which some of these aspects are controlled is normally 
the responsibility of the members of staff conducting the 
test. For the purpose of learning, QA and service improve-
ment, simple, short- term audits are an effective way of 
measuring practice against local and national standards. 
In order to complete a process of audit, there has to be 
feedback at the end to those involved in the process, that 
being referring clinicians or test operators. Plan, do, 
check and act cycle is an easy and practical method to 
use, with each cycle lasting no longer than 1 or 2 months. 
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Our recommended regular short- term audit processes 
are detailed in table 3.
All the recommended audit processes detailed as 
follows should be complemented with simple descriptive 
statistics and performed at regular time intervals (eg, 
every 6 months). Over time, assuming that, at the end of 
each audit cycle, clear and constructive feedback is given 
to the stakeholders, one would only expect an increase in 
standards and ultimately quality and assurance in service 
provision.
Equipment
Standard CPET equipment consists of the following 
components (figure 2).
QC must not be regarded as a tick box exercise. A well- 
designed QC routine is ingrained within day- to- day activ-
ities, provides factual evidence of reliability, and allows 
a proactive stance at detecting, correcting and reducing 
equipment- related sources of error. Serial QC data are 
the excellence hallmark of CPET service provision.
All equipment directly or indirectly used for CPET 
must be regularly serviced, calibrated and quality 
controlled.8 9 31 An easily accessible, up- to- date log of all 
interventions (repairs, troubleshooting, service history, 
calibrations, biological controls and respective coeffi-
cient of variance for the different output measures) must 
be kept within the exercise service. All logs must be kept 
for a period of at least 2 years.32 Older logs should be 
Table 2 Common sources of error in CPET testing
Source of error Description Impact on data
Patient Failure to follow information 
disclosed on patient information 
leaflet
All patients should be given a patient 
information leaflet and/or advice on what to 
avoid prior to performing an exercise test.
Various implications, specifically limiting 
exercise tolerance and impairing gas 
exchange data
Poor effort/cooperation/motivation 
to perform exercise test
Patients need to understand the reason why 
the test is being performed. Failure to do so 
may result in suboptimal effort.
Underestimation of all indices, including 
workload, AT, VO2 and VCO2.
Test operator Failure to give standardised 
instruction and encouragement 
during exercise
Throughout the different phases of exercise, 
there should be clear and standardised 
instructions to patients.
Various implications, specifically lack of 
consistency in data across different test 
operators
Failure to select correct load (watts) 
in view of patient’s activity level/
fitness
Incremental workloads that result in exercise 
duration of <8 or >12 min do not accurately 
reflect aerobic status.
Various implications, although more 
commonly underestimation of gas 
exchange indices
Lack awareness/guidance on the 
use of well- defined end of test 
criteria
Exercise may be stopped too early or too late 
in what should be a symptom limited exercise 
test.
If exercise is stopped early (eg, pulse 
rate), gas exchange indices can be 
underestimated.
Incorrect determination/
identification of the AT
There should be a clear definition of what AT is 
and processes in place to promote discussion 
and review agreement.
Inappropriate estimation of level of 
fitness or degree of impairment in O2 
delivery/use
Incorrect determination/
measurement of slopes 
(ΔVE/ΔVCO2, OUES and ΔVO2/ΔWR)
The determination of slopes based on linear 
regression models require correct identification 
of the start and end points.
Incorrect inferences from data (VE/VCO2 
mismatch, cardiovascular impairment, 
among others)
Equipment Inaccurate output of power by 
treadmill/ergometer
Treadmill (speed/grade) and ergometer 
(resistance) power outputs require yearly 
servicing (more often if regularly moved).
Various implications, particularly 
overestimation or underestimation of gas 
exchange indices
Non- calibrated weighing scales 
and stadiometer
Weighing scales and stadiometers require 
regular servicing and calibration if there is a 
suspicion of erroneous measurements.
Incorrect estimation of predicted data 
and consequent inaccurate inferences 
from recorded data
Excessive condensation at the 
point of gas analysis
Gas analysis should meet BTPS conditions, 
particularly humidity/water vapour pressure.
Various implications, although more 
commonly underestimation of gas 
exchange indices
Volume drift Thermal or offset volume drift may occur as a 
result of large fluctuations in temperature or 
incorrect calibration
Various implications, particularly 
inaccurate ventilatory and gas exchange 
indices
Delayed response time and transit 
time in gas exchange parameters
Under certain testing conditions, there may be 
delay from the point of sampling to the point of 
gas analysis.
Normally, underestimation of gas 
exchange data due to dispersion of 
expired gases
High/low sampling rates/delta time/
data averaging of gas exchange 
data
Data averaging below 30 or above 60 s will 
affect validity of gas exchange measurements.
Either high fluctuations or excessive 
attenuation in gas exchange data
AT, anaerobic threshold; BTPS, body temperature and pressure saturated; CPET, cardiopulmonary exercise testing; OUES, oxygen uptake efficiency 
slope; VE/VCO2, ventilatory equivalent for carbon dioxide production; ΔVE/ΔVCO2, slope of the ventilatory response; ΔVO2/ΔWR, slope of the 
metabolic response.
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scanned and saved electronically should a review of this 
information be required in the foreseeable future.
Planned preventative maintenance (PPM)
Routine day- to- day maintenance is essential to keep 
equipment in prime condition. A PPM schedule specifies 
what intervention is needed at what interval. The system 
used to track PPM (commonly a logbook) should iden-
tify when an intervention is due and then when it was 
performed and by whom. Items recorded will depend 
on the actual equipment in use but must include the 
manufacturer’s service visits and replacement of parts, 
including software updates.
Servicing of equipment should be carried out at the 
frequency recommended by the manufacturer but should 
not exceed a period of 12 months, using appropriately 
qualified and authorised personnel. Following service 
visits, the authorised agent should certify that the equip-
ment is working to specification before it is returned to 
clinical use.
Servicing and maintenance
During laboratory downtime, all equipment should 
be subject to a series of checks.31 We recommend this 
should occur on a weekly basis and/or additionally 
when concerns arise around equipment performance. 
Manufacturer- specific recommendations should be 
followed in terms of equipment components that need 
to be checked. This will involve
 ► Evaluation of integrity of reusable pieces of equip-
ment (flow sensors and sample lines).
 ► Review of serial data recorded during physical/
biological controls.
 ► Checking of gas cylinders (expiry date, pressure and 
remaining capacity).
 ► Wired connections and system leaks.
On a yearly basis, equipment must be subject to servicing 
by the manufacturer. We recommend service contracts be 
in place to ensure technical support is readily available 
when an equipment fault is suspected. Servicing of CPET 
equipment should include
 ► Ambient conditions (accuracy).
 ► Flow/volume calibration (accuracy and linearity).
 ► Gas analyser calibration (response time and delay 
time, accuracy and linearity).
 ► Treadmill (speed and grade).
 ► Cycle ergometer (calibration and validation of 
power).
 ► Pulse oximetry (accuracy).
 ► Electrocardiography (deflection and rate).
Table 3 Recommended regular short- term audit processes
Audit processes
Audit Purpose Actions
Quality of referral 
information
Do referral forms provide 
sufficient information?
1. Review all referrals for CPET (identify information asked that is not given).
2. ‘Brainstorm’ practical implications for patient and service provision.




Are patients being given 
patient information?
1. Check on day of test if patients have been given an information leaflet.
2. In those who received a leaflet, check adherence to recommendations given.




on the day of 
testing
Are different test operators 
giving set instructions?
1. Supervise test performance blindly and note time and instructions given.
2. Note noise in the room, interruptions that may disturb the patient.
3. Feedback findings to the team and develop a plan to improve test environment.
Correct power 
determination
Are patients exercising 
between 8 and 12 min?
1. Ensure same method of work rate prediction is used by all test operators.
2. Determine how many patients exercised less than 8 and more than 12 min and why.
3. Feedback to the team and raise awareness about implications of using wrong load.
Dead space 
correction
Is dead space being updated 
when using different sized 
masks?
1. Ensure method of mask size determination is performed consistently.
2. Retrospectively review data and check if dead space was updated.
3. Feedback to the team and raise awareness about implications of not correcting dead 
space.
Leak at peak 
exercise
How often does it occur and 
what are the implications?
1. Add a graph to monitoring screen plotting VTin against VTex.
2. Retrospectively review information and identify number of cases with leak at peak 
ventilation.
3. Review mask fitting technique.
Post- test review Are different members of staff 
reviewing the information 
consistently?
1. Anonymise at least 10 tests and ask team to measure slopes and determine AT.
2. Check for agreement and promote discussion.
3. Reassess competency.
Patient satisfaction Are patients satisfied with the 
service?
1. Provide patients an opportunity to give feedback.
2. Identify areas of concern or areas which can be improved.
3. Feedback to the team and implement changes.
CPET, cardiopulmonary exercise testing.
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 ► Blood pressure (leaks and accuracy of pressure 
transducer).
The engineer on site must be able to provide at the 
end of the servicing visit a detailed description of correc-
tive actions. This document should be kept in a folder as 
evidence of regular service history.
Calibration and verification
The terms calibration and verification are sometimes 
used interchangeably but refer to different procedures 
in the QC process.
1. Calibration: changing the relationship between the in-
put (measured parameters such as FeO2) and the out-
put as measured and displayed on the equipment and 
applying this change to future measurements.
2. Verification: checking the relationship between the 
input (measured parameters such as FeO2) and the 
output as measured and displayed on the equipment, 
but not making intrinsic changes to how that measure-
ment is being made.
Prior to purchasing a piece of equipment, the manu-
facturer should
1. Explain measurement principles of each sensor, how 
they are combined and any calculation or corrections 
that are used. This should include which procedures 
act as calibrations and which are only verifications.
2. Provide evidence for accuracy and repeatability of each 
sensor and the overall measurement. That may be a 
white paper, an internal audit or even independently 
published articles.
3. Demonstrate how to correctly calibrate or verify each 
sensor and explain what constitutes a pass or fail. Be 
aware there are often arbitrary values used to define 
‘out of range’, and most devices will not detect some 
of the subtler problems that may be detected by using 
the procedures described in this document.
It is the responsibility of the laboratory personnel to 
monitor and maintain the accuracy and repeatability of 
their measurements by performing calibration and veri-
fication prior to every patient test. It is imperative that 
calibration data are recorded, trended and interpreted in 
the same way as biological control data. The data should 
be interrogated regularly on the day of testing and on 
a weekly basis. Although not always practical, best prac-
tice would see this performed after every verification to 
ensure there is no ‘out of control’ or ‘warning’ to identify 
the expected calibration values for each piece of equip-
ment and to identify subtle trends. Westgard’s rules for 
QC (see Physical QC section for more details) should be 
used to quantitatively analyse these trends.
A good example of where this is essential is when 
examining a common misconception about calibrations. 
Specifically, some manufacturers use the percentage 
change from the previous calibration to flag ‘faulty’ cali-
brations. In the following example, the CO2 analyser gain 
is highlighted as out of range because the percentage 
change from the previous calibration is large (arbitrary 
values are often chosen, in this case greater than 5%). In 
a continuation of this misapprehension, users are encour-
aged to repeat the same calibration and this appears to 
‘fix’ the problem. However, when seen in the context 
of a trend (figure 3), it becomes clear that the afore-
mentioned interpretation is misleading. This outcome 
can result from two opposite situations with contrasting 
consequences.
In one situation A, a user performs an incorrect cali-
bration (eg, with a damaged sample line) and does not 
check the gain value before saving the new calibration, 
thus saving a value out of the expected range. When a 
Figure 3 Calibration example situation A trend data.
Figure 2 Standard CPET equipment. CPET, 
cardiopulmonary exercise testing. 1, blood pressure 
monitor; 2, mask, volume sensor and gas analyser tubing; 
3, 12- lead ECG; 4, ergometer (cycle, treadmill, arm crank, 
etc); 5, pulse oximeter (finger, earlobe and forehead 
placement); 6, gas analyser; 7, display of breath by breath 
data and exercise ECG. CPET, cardiopulmonary exercise 
testing.
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subsequent calibration (using an undamaged sample 
line) is performed, the user gets values as described in 
table 4i, flagging this calibration as an error when in 
fact the value has dropped back down into the expected 
range. When another calibration is performed (table 4ii) 
in an attempt to fix the problem, there is no change in 
the gain and the calibration is a ‘pass’ according to the 
device. In fact, both calibrations were a pass and the 
second one was not required. There was nothing to fix 
but a faulty calibration has gone unnoticed.
In alternative situation B, the device is performing 
normally until the user performs an incorrect calibra-
tion, for example, with a damaged flow sensor. The device 
flags the calibration as having deviated from the previous 
one by an unacceptable percentage, giving the values 
in table 5i. Again, in an attempt to fix the problem, the 
user repeats the calibration (table 5ii). However, because 
the faulty sensor is still in place, the gain value does not 
change from the previous incorrect value and the device 
‘passes’ this calibration. Rather than being fixed, this 
only signifies that this calibration is equally as bad as the 
previous one, but this fault will now go unnoticed.
Looking at the device data in isolation (tables 4 and 5) 
does not allow the user to discriminate between these situ-
ations. Looking at trends A and B (figures 3 and 4) allows 
the user to identify what has happened from the first cali-
bration attempt. In A, no second calibration is required, 
but the fact that a previous calibration error went unde-
tected should be flagged and any test performed on that 
date should be re- examined. In B, the out of range gain 
should prompt a fault- finding procedure that should 
detect the faulty sensor. Once this is replaced, the gain 
value will drop back within range and clinical testing can 
be performed.
Physical QC
QC using physical (mechanical) or non- biological 
methods is often incorrectly denominated calibration. 
It is no more than a one- point or two- point verification 
between the measurement sensor and a volume or gas 
of a known composition. ‘True’ calibration is normally 
performed at factory level or on site by service engineers. 
The equipment used to perform calibrations is expen-
sive and cumbersome and usually not readily available in 
a clinical environment. The use of simulators and mass 
flow sensors is described in literature, but its applicability 
seems to be more of interest for research purposes.8 9
The number of manufacturers with commercially 
available exercise testing equipment integrated with gas 
exchange has risen greatly over the last few years. It is 
therefore difficult to stereotype the type of flow, volumes 
and gas analysis methods used in current practice. In 
case of doubt, manufacturer recommendations must be 
followed to ensure the testing system is in good working 
condition.
Ambient conditions are normally measured by built- in 
sensors in the testing system. Ideally, these sensors should 
be open to room air but as close as possible to the gas 
analysers. It is good practice to verify measurements of 
humidity, barometric pressure and temperature on a 
daily basis against a validated weather station (table 6). 
Ambient conditions should be measured and entered 
into the software immediately prior to a test.
There are well- known advantages and caveats of a series 
of volume and flow measuring devices. These differences 
are well described elsewhere.33 Regardless of the type of 
volume/flow sensor, verification of volumes and flows 
should be performed before each test using the same 
breathing circuit used during testing. Calibration should 
be performed in a manner consistent with the manu-
facturer’s guidance, but a follow- up verification should 
be performed with a 3 L syringe to check flow depen-
dence. This should use a wide variety of flow rates, and 
the resulting volume should be within the recommended 
repeatability (table 7). Ultimately, these sensors should 
comply with European Respiratory Society (ERS)/Amer-
ican Thoracic Society (ATS) standards for spirometers.34
Table 4 Calibration example situation A
Situation A
(i) Incorrect ‘fail’
  Previous Current % Diff
  1.077 1.023 −5.0%
(ii) Correct ‘pass’ but unnecessary
  Previous Current % Diff
  1.023 1.021 −0.2%
Table 5 Calibration example situation B
Situation B
(i) Correct ‘fail’
  Previous Current % Diff
  1.022 1.077 5.4%
(ii) Incorrect ‘pass’
  Previous Current % Diff
  1.077 1.073 −0.4%
Figure 4 Calibration example situation B trend data.
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Douglas bags or systems which use mixing chambers 
are rarely used in clinical practice, so this description 
pertains to breath- by- breath systems which most clinical 
laboratories use. These systems employ ‘fast’ gas analy-
sers with rapid analyser response times and specified 
delay times.
All analysers are affected by water vapour concentra-
tion and consequent condensation at the point of anal-
ysis. The use of a sulfuric acid lined Teflon tubing allows 
the addition (during verification) or removal (during 
testing) of moisture from gas samples. This means that 
by the point the expired gas reaches the analysers, the 
water vapour should be equivalent to ambient condi-
tions, which is neither wet nor dry.
It is paramount, however, that every verification is 
performed with a clean and properly dried breathing 
circuit, including the sampling line. With regular usage, 
the latter will need to be replaced, particularly when 
the transparent appearance becomes yellow/orange in 
colour (saturated). It is also good practice to ensure the 
dead space input on the testing system is actually correct 
(this can normally be found in the equipment manual). 
The process of verification should consist of a two- point 
verification, normally to room air and to the gas cylinder 
mixture (table 8). The use of a second gas cylinder with 
different composition to test the accuracy and precision 
of the analysers at the extreme of measurable ranges is 
considered good practice (eg, 26% oxygen cylinder, 
nitrogen balance).
Although unlikely, it is possible, for calibration gas to be 
supplied with an unacceptable variance from the labelled 
concentrations. In this situation the device may pass cali-
bration but may result in significant variance from biolog-
ical controls. For this reason, it is best practice to store an 
additional gas bottle for use for fault finding or in the 
event of the routine gas bottle running out.
Procedures vary from one manufacturer to the next, 
but there are generally at least four parameters to be 
determined by a gas calibration:
1. Slope: often referred to as ‘gain’, it is the ratio of 
change in the input parameter versus change in out-
put parameter. The slope is one of two parts to the 
equation used to linearise the relationship between 
the upper and lower gas calibration concentrations.
2. Offset: the ‘offset’ is where the calibration line crosses 
the Y- axis.
3. Delay time: the time from when the gas is introduced 
into the system to when it is detected by the gas anal-
ysers. The delay time is dictated by the length of the 
sampling tube.
4. Response time: the inherent ‘response time’ of the sys-
tem which has a predictable time constant.
It is worth noting that the processes described previously 
are a simplification of what actually happens in commer-
cially available metabolic carts, and even different models 
from the same manufacturer can differ in their princi-
ples of operation. It is important to be aware of the afore-
mentioned general principles, but equally, it is unfair to 
expect that all systems will operate identically. As a result, 
operators and clinicians should take a keen interest in 
the particulars of their own specific equipment and, as 
previously mentioned, ask their supplier detailed ques-
tions about its internal workings.
Gas calibration should be performed prior to testing. 
Calibration should be repeated if any part of the gas 
sampling apparatus is changed between tests, for 
example, the gas sample line. This is particularly perti-
nent for systems which use oxygen analysers that react 
with O2 to produce a voltage and, in the process, consume 
themselves. These types of ‘cell’ change their voltage to 
gas concentration relationship over time. As such, care 
should be taken to ascertain over what period of time this 
relationship changes. It should not result in a measurable 
difference over the length of time that a normal test takes. 
To do this, calibrate the system as normal, then perform 
a biological control test. After the test is complete, run a 
verification of the calibration and check that the variance 
is within the expected range. If the gain has increased 
Table 6 Calibration and verification methods and frequencies for various ambient condition sensors
Ambient conditions
Method/sensor Verification/calibration Frequency
Hygrometer, thermometer, barometer, 
pressure/barometric altimeter
Validated weather station (check for 
agreement ±3%)
Daily/sessional or before each test if 
unable to control ambient temperature
Table 7 Calibration and verification methods and frequencies for various volume and flow sensors
Volume (L) and flow (L/s)
Method/sensor Verification/calibration Frequency
Pneumotachograph Manual
Validated 3 L syringe (±3%) using low, mid and high flows34
Automatic (equipment)
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over that short period of time, it may indicate that the 
‘O2 cell’ is coming to the end of its life and needs to be 
replaced.
As a result of performing regular physical QC proce-
dures, there is often a considerable amount of data that 
can be used to further provide evidence on the stability 
of the measuring equipment. This often does not take 
place in clinical practice and may mask potential trends 
in equipment function that are not readily noticeable 
when comparing single verifications. In most testing 
systems, the calibration data is easily transferable to an 
Excel spreadsheet, where basic descriptive statistics can 
be performed to explore the data. The work of Westgard 
and colleagues35 details a series of steps to understand 
variation within the data as well as a group of criteria to 
identify ‘out of control’ conditions. Once processed this 
information can be easily plotted in a Levey- Jennings 
control chart (mean, 2 SDs and 3 SDs from mean) to 
visually and very intuitively check whether there are data 
trends that could meet an ‘out of control” condition. 
Figure 5 describes and depicts ‘out of control” conditions 
according to Westgard and Barry.36
Treadmill and cycle ergometers are commonly used to 
generate a measurable workload during exercise testing. 
Inaccuracies in power output, particularly in cycle ergom-
eters, have been reported in literature and can vary as 
much as 18%.37 This has significant implications on the 
measurable gas exchange parameters. There are fewer 
reports implicating inaccuracies in the use of treadmill 
ergometry; however, the process of verification should be 
regarded as equally important (tables 9 and 10).
Both methods of testing should be subject to verifi-
cation and calibration (if required) when moved. The 
equipment required is often not readily available in respi-
ratory laboratories as it is expensive and bulky. Alterna-
tive, supposedly simpler, verification methods have been 
described,38 39 but their practical application is difficult 
and likely to generate confusion rather than assurance. 
In view of this, constant workload biological QC testing 
is perhaps the best way of ensuring adequate working 
conditions on a short- term basis. In case of doubt, service 
engineers should be called onsite to investigate the 
problem or carry out required maintenance or servicing, 
as required.
Other equipment, not directly related with CPET testing 
systems, should be regularly verified. This includes stadi-
ometers, weighing scales, blood gas analysers, manual 
blood pressure cuffs and automatic defibrillators. The 
clinical engineering department will often be responsible 
to ensure the equipment listed previously is regularly 
serviced, is in good working condition and is compliant 
with electrical safety requirements.
Biological QC
Regular biological QC (also referred to as physiological 
control) using one or more healthy testing subjects at 
regular intervals, similar time of day and under controlled 
conditions, is important to monitor the precision of the 
testing equipment as a whole.40 Healthy testing subjects 
could be drawn from volunteering staff members. They 
should be free from test contraindications and consent 
for their data to be used for QC purposes. Using healthy 
subjects who are practised and familiar with the equip-
ment and QC protocol is recommended and has been 
shown to return very little biological variability.40 Biolog-
ical QC allows a holistic evaluation of the testing system 
and can uncover systematic errors that physical methods 
alone are not able to.41 Testing should be carried out 
during protected laboratory downtime. There are 
currently three different protocol designs which can be 
used as part of a biological QC programme. We recom-
mend that one or more of these protocols are deployed 
on a weekly basis:
 ► Incremental ramp (to monitor precision of flow and 
gas measuring devices at the extremes of working 
ranges).
 ► Constant work protocol (to monitor serial precision 
and stability of flow and gas measuring devices as well 
as rule out indirect sources of bias).
 ► Isotime protocol (allows for direct measurement of 
the dynamic slopes used in CPET interpretation).
Services should produce and maintain standard oper-
ating procedures which detail the QC protocol or proto-
cols in use currently within that service.
Incremental ramp protocol
During incremental ramp the test can be conducted 
if used on the exact same terms as it is performed in 
patients. Initially, at a shorter time interval, serial tests 
should be performed to determine baseline mean values 
to then allow ongoing comparison with less frequent 
testing to calculate the coefficient of variation (CoV). 
Previous data has been published on what is considered 
to be acceptable CoV.32 41 This is shown in table 11.
Table 8 Calibration and verification methods and frequencies for various O2 and CO2 gas analysers
O2 and CO2 gas analysers
Method/sensor Verification/calibration Frequency
Mass spectrometers/infrared 2- point calibration
Known FiO2 and FiCO2 (±1%)
8 9
Mass flow sensor/simulator
21% O2 in N2 (balance) at (x) flow (±1%)
Before each test
Electrochemical Not common in clinical setting
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Constant work protocol
The constant work protocol has been presented by other 
authors.11 It involves the use of at least two power outputs, 
low from around 30 to 60 W and high, from 70 to 100 
W. It is imperative that both work rates (WRs) are suban-
aerobic threshold. The testing subject should be able to 
tolerate both loads for at least 6 min. Once again, testing 
should be performed in similar conditions to patient 
testing. The protocol should start with at least 3 min of 
baseline measurements, followed by 3 min of unloaded 
cycling, 6 min at a low and constant load and finally a 
further 6 min at a high and constant loads (figure 6). It 
is expected that within 3 min of pedalling at a constant 
load, gas exchange parameters reach a steady state. Mean 
values for parameters such as VO2, VCO2 and VE should 
be derived from the steady- state portion of the test. These 
Figure 5 Example of Westgard criteria plotted in a Levey- Jennings chart which can be used to visually and intuitively identify 
data trends that could meet an ‘out of control’ condition.35 36
Table 9 Calibration and verification methods and frequencies for various cycle ergometers
Cycle ergometry (power output)
Method/sensor Verification/calibration Frequency
Mechanically braked ±2% or ±3 W (above 25 W)8 9
Dynamic torque Metre, specialist, not 
readily available equipment (often 
performed by manufacturer)
Yearly as part of servicing, when 
moved or on suspicion of malfunctionElectromagnetically braked
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data should be recorded in a database for serial analysis 
and identification of differences in expected variables. 
The Westgard rules, described previously, should be 
applied to these data, however, it is important to note 
that the use of Westgard rules to monitor biological QC 
data may not inform that an error is about to happen and 
may miss actual errors due to subject variability.42
The relationship between VO2 and WR is a useful 
measure to record as it provides an overall ‘sense check’ 
of the testing equipment. In health, one would expect 
an increase in VO2 of approximately 10 mL/min/W 
increase in WR; therefore, the measured change in VO2 
between two differing constant WR protocols would be 
directly proportional to the difference in WR by a factor 
of 10. ΔVO2/ΔWR values which deviate above or below 
the 95% CI (~8.5 to 12.5 mL/min/W)43 44 should raise 
suspicion of a significant deviation in the measurement.11
Isotime protocol
The steady- state method of QC is the reference method 
for biological control with considerable supporting 
evidence; however, it can be time consuming. Between 
set- up and waiting for gas kinetics to stabilise, there is a 
large portion of the procedure which does not contribute 
to the outcomes. This method also suffers from a lack 
of specificity because it uses steady- state measurements 
to infer the accuracy of an incremental test. Using a 
submaximal incremental protocol and measuring values 
at isotime points during the test are an alternative that 
has the convenience of being more practical and more 
activity specific. It also allows for direct measurement of 
the dynamic slopes used in CPET interpretation.
The protocol starts with a ‘check’ phase to ensure the 
resting data are stable before proceeding. Resting data 
are captured for 3 min before starting an unloaded phase 
where the subject pedals at approximately 60–80 revs/
min with no applied WR (0 Watts) for a further 3 min. 
Providing the respiratory exchange ratio (RER) is stable 
the ramp phase is started at an increment of between 15 
and 30 W/min. The increment used can be determined 
from the subject’s previous maximal ramp tests and 
adjusted with the aim of obtaining repeatable submax-
imal data over a clinically relevant time course that is 
equivalent to a normal patient test, specifically 8 min. It 
is important that subsequent tests use the same cadence 
and ramp increment. After 8 min, pedalling is stopped. 
If recovery data are of interest, the subject can remain on 
the ergometer for an additional 3 min.
Measurement of all relevant parameters can be sampled 
at 2.5, 5.0 and 7.5 min. Providing the same averaging 
that is used during clinical tests is applied, each isotime 
should only use a single data point. The slopes should 
use a statistical ‘best fit’ average between 2.5 and 7.5 
min to avoid interoperator variability. The first 2.5 min 
is omitted in order to exclude gas kinetic curves at the 
onset of the WR ramp. An example of data taken at an 
isotime of 5.0 min during this type of protocol is shown in 
table 12. This is averaged over the last 10 tests and shows 
the type of variability that can be expected.
Where multiple exercise testing systems are available, 
efforts to exercise the same biological control in different 
pieces of equipment are highly recommended. Ideally, a 
difference in measured gas exchange variables of no more 
than ±5% should be witnessed. In real terms, however, 
this can normally be expected to increase to ±10% and 
still be considered acceptable. Patients who are expected 
to perform serial exercise tests should always be set up 
on the same testing system to decrease sources of non- 
physiological bias.
Regardless of the type of protocol used for biological 
QC, there are important technical aspects inherent to the 
method of gas exchange analysis that need to be taken 
into account. Most systems in use have adopted the breath- 
by- breath method, although there are mixed reviews on 
whether mixing chamber systems may be superior.45 The 
latter requires ponderous consideration between tidal 
volume and size of the mixing bag.31 Inappropriate equip-
ment selection in this method would result in either large 
Table 10 Calibration and verification methods and frequencies for treadmill
Treadmill (speed and grade)
Method/sensor Verification/calibration Frequency
Manual/digital control ±0.2 mph and ±0.5% grade8 9
Time revolution of belt and carpenter’s rule. 
Specialist, not readily available equipment 
(often performed by manufacturer)
Yearly as part of servicing, when move, or 
on suspicion of malfunction
Table 11 CoV standards for various physiological variables measured during a biological quality control programme
Biological QC standards for CPET
Variable HR BF VE VO2 VCO2 RER VTex ΔVO2/ΔWR ΔVE/ΔVCO2
CoV 5% 8% 8% 6% 6% 8% 8% 10% 10%
BF, breathing frequency; CoV, coefficient of variation; CPET, cardiopulmonary exercise testing; RER, respiratory exchange ratio; VTex, 
expiratory tidal volume.
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or subtle fluctuations in gas concentration affecting the 
validity of measurements. A similar argument is raised as 
an issue in breath- by- breath systems with regard to lack of 
standardisation in sampling rates and consequent effect 
on measured VO2 and VCO2.
46 Signal averaging between 
30 and 60 s, as long as unchanged across serial measure-
ments and is consistently adopted within the laboratory 
protocol, is considered normal practice in a clinical 
setting.8
Facilities
The exercise laboratory should be free of clutter and 
welcoming to patients. CPET equipment often varies 
in size and may consist of any combination of bicycle 
ergometer, arm crank ergometer, treadmill, ECG, blood 
pressure monitoring equipment and ventilatory gas 
exchange analyser. It is therefore important that the 
exercise laboratory is not only large enough to accommo-
date such equipment but also provides enough space to 
enable staff and patients to walk around freely, allowing 
adequate access to the patient in case of an emergency.47
Patients may be easily distracted during the test 
protocol. Where possible, monitoring screens should 
not be visible to the patient. Dialogue between test oper-
ators must be kept to a minimum as this can distract the 
patient and potentially alter peak values. The position of 
the ergometer in relation to the system cart must allow 
clear communication. Communication between the 
patient (hand gestures) and the test operator (verbal 
feedback and encouragement) is key and predisposes to 
maximal effort.
Figure 6 Graphical representation of the constant work 
protocol used during a biological quality control session. 
Steady- state VO2 at 60 and 100 W is collected in a normal 
healthy control subject.
Table 12 Example of data taken at an isotime of 5 min during an isotime quality control protocol; this is averaged over the 




Power W 190 0.5
HR beats/min 117 3.1
VO2 mL/min 2608 4.1
VCO2 mL/min 2091 3.7
SPO2 % 99 1.0
RPM revs/min 79 2.0
BF breaths/min 27 14.1
VE L/min 63 5.3
VTEX L 2 11.0
PETCO2 kPa 5 3.5




BPSYS mm Hg 150 13.1
BPDIA mm Hg 69 11.9
ΔHR/ΔVO2 beats/mL 23 10.3
ΔVE/ΔVCO2 27 7.1
ΔVO2/ΔWR mL/min/W 10 5.7
ΔVO2/ΔLOG10VE 4902 10.0
Source: P. Jamieson Respiratory Laboratory, Hairmyres Hospital, NHS Lanarkshire, UK.
16 Pritchard A, et al. BMJ Open Resp Res 2021;8:e001121. doi:10.1136/bmjresp-2021-001121
Open access
Resuscitation facilities must be available in the event 
of a cardiac/respiratory arrest and must include an auto-
matic external defibrillator (AED), arrest trolley, oxygen 
and suction in line with current UK Resuscitation Council 
guidelines.48 This equipment should be checked and 
deemed fully functional before the start of each testing 
session. There must also be a system in place for rapidly 
summoning a hospital arrest team in case of an emer-
gency, for example, an alarm switch or telephone bleep 
system. All staff working in the area must be fully briefed 
on the protocol for summoning the hospital arrest team 
before participating in CPET.
The laboratory should be positioned, within the 
hospital, in such a way as to allow fast access from the 
arrest team. There should be a private area within the 
exercise laboratory which patients can use for changing 
clothes before and after the test, and efforts to maintain 
privacy throughout the test should be made; this includes 
minimising interruptions throughout the test49 and 
ensuring that only required members of staff are present 
during the CPET.
The testing area should be clean, well lit and well 
ventilated in line with health and safety guidelines50 and 
ARTP guidance.47 Furthermore, the laboratory should be 
temperature and humidity controlled, where possible, as 
heart rate and rating of perceived exertion increase as 
ambient temperature increases.49 The American Heart 
Association has made recommendations that a tempera-
ture of between 20°C and 22°C is comfortable for the 
patient to exercise and suggest that a cooler dryer exer-
cise environment enhances cutaneous heat exchange, 
helping to dissipate heat generated by exercise.49 The 
laboratory should contain a thermometer, barometer 
and hygrometer to allow gas exchange measurements to 
be adjusted for ambient conditions.
Although CPET testing has been historically performed 
under physician supervision due to the additional risk of 
cardiac arrest during or soon after vigorous exercise,51 
it has been concluded that the risk of medical compli-
cations is related to the underlying disease, rather than 
the test itself, and the mortality rate for patients during 
exercise testing is 2–5 per 100 000 clinical exercise tests.8 
A comparison of CPET performed by physicians and 
by trained physiologists/nurses suggests that the inci-
dence of adverse events during CPET is no different.51 
It is therefore now widely accepted that CPET can be 
safely performed by adequately trained and experienced 
healthcare professionals.
Personnel
A minimum of two qualified healthcare professionals are 
required to safely perform CPET and should be present 
during the exercise and recovery stage of the test.52 A 
physician should be present for the CPET if deemed 
necessary by the referring physician or if the healthcare 
professionals performing the test believe the patient is 
at sufficient risk of developing complications during 
testing.11 Ultimately, a physician should be immediately 
available during all exercise tests52 53 if required. Health-
care professionals from several disciplines may possess 
the training and experience required to competently 
perform CPET.49 These include physiologists working 
within the field of respiratory or cardiology, exercise 
physiologists, nursing staff and physician assistants.
If tests are performed within a secondary care centre 
or acute NHS Trust, where there is rapid access to an 
arrest trolley and emergency resuscitation (crash) team, 
we recommend that healthcare professionals performing 
CPET be trained in basic life support with AED. If CPET 
is performed in any other location, we recommend that 
healthcare professionals performing CPET are trained to 
the level of immediate life support (ILS).
Leadership
The test must be led by a competent CPET practitioner. 
It is the role of the lead practitioner to accurately review 
the medical history,49 supervise the test and ensure that 
all protocols are followed correctly regarding test proce-
dure. It is the role of the lead practitioner to interpret the 
test data and produce an accurate report while ensuring 
that all absolute contraindications have been excluded 
before commencing the test and ensuring that staff 
involved with the test are suitably qualified.52
The second practitioner required for CPET should 
work in an assisting role52 and should be assessed as 
competent to assist in line with local departmental poli-
cies. The role of the assistant may include duties such 
as performing accurate calibration of the test equip-
ment before each CPET, preparing the patient pretest 
by accurately positioning the 12- lead ECG electrodes, 
performing any pretest procedures such as pulmonary 
function testing or capillary blood gas testing, encour-
aging the patient throughout the CPET as instructed by 
the lead practitioner and assisting in the safe recovery of 
the patient following the exercise test. It is vital that both 
the supervisor and assistant are fully aware of the indica-
tions for test termination and that either member of staff 
may end the test when required.
Competency
All competent CPET practitioners must be able to iden-
tify and manage adverse events in relation to CPET by 
discriminating between normal and abnormal responses 
to exercise.11 The lead practitioner will have extensive 
exercise test experience and practical or academic knowl-
edge attained through a formal training programme, 
for example, a CPET- specific course which provides the 
underpinning knowledge required to safely perform and 
interpret the CPET. The lead practitioner should have an 
advanced knowledge of ECG interpretation.
Levels of competency will reflect the specific require-
ments of the service and may differ between services. 
However, in line with other organisations,11 CPET prac-
titioners who will be performing and reporting CPET 
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tests should have completed a suitable course, provided 
by an accredited organisation, and covering key learning 
outcomes (box 5).
Additionally, the competency pathways detailed in 
figure 7 should be followed to ensure competency to 
perform CPET in a lead practitioner role and/or compe-
tency to report CPET. Where possible, new practitioners 
working towards competency should expose themselves 
to a mixed cohort of patient testing; this should include 
patients referred for diagnostic or preoperative assess-
ment and patients referred from differing specialities, for 
example, respiratory or cardiology.
Once a practitioner is deemed to be competent to 
perform or report CPET, ongoing maintenance of compe-
tency is essential to minimise clinical risk and potential 
adverse events. Primarily, competence is maintained 
with frequent performance of CPET. We would suggest 
a minimum of 25 tests per year. Continued professional 
development is essential and should reflect the skills and 
knowledge base presented in current literature and clin-
ical guidelines. Additionally, routine monitoring of inter-
pretive skills and clinical reporting should be adhered 
to. This can be achieved with periodic review and over 
reading by a competent colleague. Peer review could be 
completed within the practitioner’s own service or by a 
competent colleague working within a neighbouring 
service. Gaps in knowledge identified during this process 
should be resolved with further training.
As a minimum, the assistant should be competent in 
the use of the CPET equipment52 and trained in a field 
related to the test itself while having at least a basic knowl-
edge of normal and abnormal exercise responses, and 
able to recognise an abnormal ECG,8 oxygen desatura-
tion, hypotension and hypertension.
TEST PERFORMANCE
Protocol selection
The aim of the clinical CPET is to make measurements 
of cardiorespiratory function while the patient performs 
work. The work should incrementally progress from a 
period of unloaded exercise to maximal exertion within 
approximately 8–12 min.54 When deciding which protocol 
to use during CPET, consideration should be given to the 
individual performing the test and the desired outcome 
measures: is the patient attending for preoperative 
fitness assessment or for diagnostic purposes? This ques-
tion is important for deciding the appropriate protocol. 
It is possible to estimate how rapidly WR should be 
progressed based on the patient’s predicted peak work 
load and subtracting the work of unloaded exercise. The 
following equation can be used to calculate the optimum 
cycle ergometry work increment for individual patients55:
Work rate increment=predicted VO2Max–VO2unloaded)/103
However, consideration of pulmonary function 
impairment, patient activity or fitness levels should also 
influence the practitioner’s decision as to which exer-
cise protocol will be best suited to achieve the desired 
outcome measures. In line with other authors,12 we 
recommend adjusting the protocol by ±5 W/min.
During treadmill- based CPET, belt speed and/or incline 
are adjusted over time in order to elicit an increase in 
exercise intensity. Several established protocols exist,56–58 
which are based on these principles; however, none of 
these protocols allow for a linear increase in WR as a 
ramp or minute by minute increment.12 Algorithm- based 
protocols have been developed59 more recently which 
aim to produce linear increases in WR which more closely 
replicate exercise responses seen in cycle ergometry.
Measurement principles
Pretest spirometry
Quality assured spirometry should be performed prior to 
CPET by a practitioner who is qualified and competent 
to do so. If investigating the presence of exercise induced 
Box 5 Suggested key learning outcomes which should be 
covered during any suitable cardiopulmonary exercise testing 
course provided by an accredited organisation
Key learning outcomes
 ► Normal cardiac and respiratory physiological responses to exercise.
 ► Safe practice, contraindications to test, when to terminate test.
 – Preparing the patient for the test.
 – Performing the test.
 – Protocol selection based on reason for referral.
 – Patient set- up.
 – Exercise ECG interpretation.
 – Test termination.
 – Appropriate data collection for analysis.
 ► Interpretative strategies based on reason for referral.
 ► Identifying an abnormal response to exercise.
 ► Generating an effective report and answering the clinical question.
 ► Delivering a quality assured service.
Figure 7 Recommended competence pathways for lead 
CPET practitioners and reporting CPET practitioners. CPET, 
cardiopulmonary exercise testing.
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dynamic hyperinflation, baseline measurement of inspir-
atory capacity (IC) should be completed. Forced expir-
atory volume in the first second (FEV1) and forced vital 
capacity are used to determine the presence of airway 
obstruction or a restrictive defect. For details on the 
performance of spirometry, please see the ARTP State-
ment on Lung Function 2020.14
The measurement of maximum voluntary ventilation 
(MVV) can be indirectly estimated from the spirom-
etry manoeuvre. This approach has now superseded the 
direct measurement of MVV60 and is not recommended 
here. There are many methods suggested in the litera-
ture for indirect estimation of MVV using various multi-
plication factors of FEV1; however, most laboratories use 
the measured FEV1×40 method for estimating MVV. The 
consensus opinion of the authors of this document is that 
MVV should be estimated indirectly by multiplying the 
measured FEV1×40.
Basic components
There should be five basic components to any cardiopul-
monary exercise protocol (figure 8).
1. Check phase: during the check phase, the patient is 
attached to all equipment and visualisation of the out-
puts is made possible. This is an opportunity to ensure 
there are no software or hardware issues before any 
measurements are made and that all parameters ap-
pear to be reasonable and physiologically plausible.
2. Rest phase: during rest, all parameters are being re-
corded without any exercise being performed. This 
is an opportunity to determine whether there are any 
resting physiological variables that may be influencing 
exercise performance (eg, resting hyperventilation). 
This phase typically lasts a minimum of 2 min and un-
til a stable baseline has been achieved.
3. Unloaded phase: this is the point in the exercise test 
where the patient performs unloaded exercise, that 
is, the metabolic demand on the system to move the 
limbs used for exercise only. It allows measurements of 
loaded exercise to be made from a true zero point. It is 
not possible to perform unloaded exercise on a tread-
mill as load is required as soon as the treadmill begins 
to move and hence is a potential drawback in using 
treadmill exercise. Unloaded exercise can only be 
truly performed using an electromagnetically braked 
cycle ergometer which will assist patients to turn their 
legs at low levels of exercise. This phase usually lasts no 
longer than 3 min.
4. Loaded phase: at this point in the exercise test, a load 
will be introduced to the patient. For the treadmill, this 
will result in an increase in speed and/or incline. For 
the cycle ergometer, an increase in resistance required 
to turn the flywheel is applied. Depending on the 
chosen protocol, this load may be introduced at low 
levels to begin and increase at specific time intervals 
(eg, step or ramp protocols) or commence at higher- 
intensity levels and remain constant for the duration 
that the patient is able to continue exercising (eg, en-
durance protocols). For cycle ergometry, the duration 
of this phase should be no less than 8 min to ensure 
the patient does not stop due to an excessive workload 
and/or that important phases during the exercise test 
are not missed. The test duration should also be no 
greater than 12 min to reduce the likelihood of the pa-
tient stopping due to something other than symptom 
limitation (eg, boredom or saddle soreness).
5. Recovery phase: during the recovery phase, load is re-
duced and variables are continually monitored to mea-
sure the patient’s ability to recover from the exercise 
protocol. The recovery phase can be terminated, for 
instance, when VO2 has returned to 50% of peak val-
ues or heart rate returns to within 20 beats/min of pre-
test resting values. Some sites choose to use the period 
as a warm- down for the patient, during which time the 
patient continues to cycle at reduced load in the hope 
of maintaining blood flow to the muscles and remov-
ing by- products of exercise (eg, lactate build- up). We 
would suggest that recovery variables are collected, 
and once targets have been achieved, a warm down is 
allowed to ensure venous return and appropriate mus-
cle recovery.
Blood gas analysis
The performance of arterial blood gas (ABG) or capil-
lary blood gas (CBG) during the rest phase and imme-
diately postexercise adds additional benefit when inves-
tigating the cause of unexplained exertional breathless-
ness. Hyperventilation and gas exchange abnormalities 
can present with similar response patterns, that is, raised 
ventilatory slope, raised ventilatory equivalents and 
reduced end- tidal carbon dioxide levels. However, to 
accurately distinguish between these response patterns, it 
is essential to understand whether there is a wide alveolar 
to arterial oxygen partial pressure difference (P(A- a)O2) 
and/or a wide end- tidal to arterial difference in carbon 
dioxide (P(a- ET)CO2) and hence the need for blood gas 
sampling. Oxygen saturation levels recorded by pulse 
oximetry are not accurate enough in all subjects to allow 
accurate distinction. If one or both of these are wider 
Figure 8 Five basic components of a standard CPET test. 
CPET, cardiopulmonary exercise testing.
Pritchard A, et al. BMJ Open Resp Res 2021;8:e001121. doi:10.1136/bmjresp-2021-001121 19
Open access
than the expected normal, then this is highly suggestive 
of a gas exchange and/or dead space problem.
Additionally, clinically relevant information on arte-
rial carbon dioxide tension, pH, bicarbonate and blood 
lactate levels can be obtained from arterialised blood 
gas sampling at rest and immediately postexercise. The 
ratio of physiological dead space ventilation (VD) to 
tidal ventilation (VT) can be calculated by the metabolic 
system using the measurement of arterial carbon dioxide 
tension. VD/VT provides further assessment of the effi-
ciency of gas exchange. Although most metabolic systems 
will provide a calculated VD/VT without measurement of 
arterial carbon dioxide tension, this is based on end tidal 
gas tensions and should be considered inaccurate.
It is important that the blood is collected while the 
patient is connected to the mask/mouthpiece and breath 
samples are being recorded. The metabolic system must 
be notified at the point at which the sample is collected 
so the breath values can be directly compared with the 
blood sample values. This ensures an accurate compar-
ison between arterial gas values and gases being inspired/
expired. For details on the performance of ABGs/CBGs, 
please see the ARTP Statement on Lung Function 2020.14
Ergometer selection
The measurement of cardiac and ventilatory responses 
to linear increases to WR enables accurate, non- invasive 
identification of exercise thresholds. A plethora of exer-
cise ergometer devices is available for measuring incre-
mental physical work during exercise testing, including 
specific machines for swimming, kayaking, Nordic skiing 
and rowing. These more specialised devices are often 
specific to exercise physiology and sports science labo-
ratories, and used predominantly in the assessment of 
athletes. In the clinical environment, cycle ergometers 
and treadmills are most commonly used as these are 
more widely available and replicate the type of activity 
which most patients can easily relate to (table 13).
Treadmills are more often used in cardiology laborato-
ries and offer the advantage of allowing exercise, which 
is more representative of daily activities for most people, 
for example, walking, jogging and running, and for this 
reason are often well tolerated by most patients. Exer-
cising on a treadmill does involve upper body muscle 
mass due to the global nature of ambulatory movement; 
the effect of this is that peak VO2 can often be 5%–10% 
higher than on a cycle ergometer.31 This is an obvious 
advantage in the assessment of athletes or those patients 
where determination of VO2peak is desirable. The disad-
vantage of increased upper body muscular involvement 
is the possibility of introducing movement artefact to 
measurement of blood pressure, oximetry, ventilatory 
and gas exchange indices. A further important factor for 
consideration when using a motorised treadmill is that 
oxygen use may be reduced if the patient requires the 
assistance of the hand rails61 due to the weight- bearing 
benefit of leaning against the equipment.
There are many established treadmill protocols used 
in clinical practice. These are often employed in cardiac 
exercise tests in which increases in ventilatory or meta-
bolic indices are not considered. Traditional tread-
mill WR protocols which use ‘stepped’ or non- uniform 
increases in belt speed and gradient are not always suit-
able for CPET as they are likely to result in non- linear 
increases in metabolic rate,59 rendering non- invasive 
detection of the anaerobic threshold difficult. Addition-
ally, protocols which call for high constant belt speed may 
not be tolerated by some clinical patients and may result 
in failure to perform the test or early termination of exer-
cise. For CPET, treadmill protocols should consist of a 
low initial WR which is increased continuously by adjust-
ment of belt speed and angle to produce a linear increase 
in work intensity56 and, therefore, metabolic rate, over an 
adequate period of time to allow sufficient physiological 
response to exercise.
Cycle ergometers are a popular alternative to the tread-
mill in the clinical setting. These devices are physically 
smaller and usually less expensive62 than most treadmills. 
Exercising on a stationary bicycle is often well tolerated 
by most individuals but may be difficult for those not 
experienced in using a cycle or those with lower limb 
orthopaedic or vascular limitations. The cycle ergom-
eter is often considered a safer option than the tread-
mill in patients who have balance or gait problems,61 for 
Table 13 Expected characteristic differences between 
cycle ergometry and treadmill modalities for CPET testing
Cycle Treadmill
Peak oxygen uptake Lower Higher
Ability to implement ramp 
protocol
Easier Harder
Quantifiable external work Yes Based on 
algorithm
Blood gas collection Easier Harder
ECG quality Higher Lower
Noise and artefacts Less More
Safety Safer Increased risk of 
falls
Weight bearing in obese Less More
Degree of leg muscle 
training
Less More
Possible use in 
recumbent position
Yes No




Ease of movement Easier Harder
Adapted from the American Thoracic Society and American 
College of Chest Physicians and Mezzani.8 90
CPET, cardiopulmonary exercise testing.
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obvious reasons. On a cycle ergometer, the patient can 
stop cycling as soon as they develop any mobility issues or 
are unable to continue the test, whereas those exercising 
on a motorised treadmill must first signal to the operator 
that they wish to stop before the belt is slowed to a stop.31
In the obese patient, use of the cycle ergometer over 
a treadmill may provide an advantage. As the patient 
is supported at all times and the nature of the exercise 
modality is less weight bearing, obese individuals who are 
unable to mobilise on a treadmill may be able to exer-
cise for a sufficient length of time to generate enough 
data for analysis. The weight restrictions on commer-
cial cycle ergometers are the obvious limiting factor in 
this instance. As an alternative to the traditional upright 
cycle ergometer, semirecumbent cycle ergometers are 
now commercially available and offer a higher ceiling on 
weight restriction. This particular cycle type is often more 
comfortable for obese individuals who may be physically 
limited by physical build in a traditional cycling position.
The advantage of using a cycle ergometer is that WR 
can be directly quantified8 and incremental WR proto-
cols can be tightly controlled to allow for smaller incre-
ments as and when required. This is particularly useful 
when elderly or frail patients are tested and require 
much more gentle increases in exercise intensity than a 
younger or fitter individual. Compared with the tread-
mill, the action of exercising on a cycle ergometer limits 
the muscular involvement of the arms and upper body. 
The obvious disadvantage of this is that peak VO2 will 
be lower compared with treadmill testing; however, this 
often reduces movement and noise artefact, which can 
otherwise make ECG, blood pressure, blood gas sampling 
and oxygen saturation analysis difficult.
Amputees and patients with sufficient disability or lower 
limb mobility issues may not be able to perform leg exer-
cise on either a cycle or treadmill. In this instance, these 
individuals can perform CPET on an arm crank ergometer 
and generate physiological response data which is similar to 
leg ergometry.63 Standalone arm crank ergometers are now 
commercially available; however, it is not uncommon for 
modified cycle ergometers to be used. There are, however, 
limitations with this exercise test modality. Primarily, the 
action required to turn an arm crank ergometer involves 
and interferes with respiratory accessory muscles.8 This 
may result in increased dyspnoea and/or the early termi-
nation of exercise in those patients with respiratory disease. 
The rhythmic nature of turning the arm crank is also not 
an action which many individuals are experienced in; this 
has also been suggested as a possible cause of early onset of 
fatigue during this exercise modality.64
Additionally, the metabolic stress induced during arm 
crank exercise is significantly lower than leg ergometry due 
to a much smaller active muscle mass61 resulting in lower 
reported peak VO2 values and earlier onset of metabolic 
acidosis.8 65 To date, arm crank ergometry has gained little 
traction in clinical assessment of patients, and this is largely 
due to lack of research in this area. It is widely accepted that 
comparing the measured physiological exercise response 
patterns to age- matched normal predicted values is common 
practice. The predicted values used should be matched 
to the appropriate exercise modality,31 an area that is still 
lacking in arm crank ergometry.
In the field of presurgical assessment via CPET, there is an 
established wealth of literature focusing on the use of cycle 
or treadmill exercise, but to date, very little exists to support 
the use of arm crank ergometry in the surgical cohort. This 
area of research is now beginning to develop and, recently, 
it has been suggested that the relationship between arm 
crank and leg ergometry is not a simple one and likely does 
not share a linear relationship based on muscle mass alone. 
While some clinical value may be obtained from CPET via 
arm crank (eg, identification of cardiac/ventilatory limita-
tion or ECG changes), values obtained through arm crank 
ergometry are poor predictors of those values obtained 
through cycle ergometry.66 As a result of this, using arm 
crank ergometry for risk stratification of surgery is an insuf-
ficient substitute for traditional leg exercise, until further 
research has been conducted in this area.
Test end criteria
The criteria for determining when the CPET operator 
should consider terminating the exercise test prema-
turely are presented in box 6. The patient and their 
symptoms should be the priority when determining if it is 
safe to continue with an exercise test.
Post-test instructions
On completion of the exercise test, the following precau-
tionary advice should be relayed to the patient before 
leaving the exercise laboratory:
 ► To not take a hot shower for at least 1 hour following 
the test. Blood vessels expand following exercise; a hot 
Box 6 Premature test termination criteria Adapted from 
Levett et al and The Society for Cardiological Science and 
Technology .11 52
Premature test termination criteria
 ► Angina:
 – Symptomatic: >2 mm ST depression.11
 – Asymptomatic: 3 mm mm ST depression.52
 – >1 mm ST elevation.
 ► Significant arrhythmias causing symptoms or haemodynamic 
compromise
 ► Fall in systolic blood pressure >20 mm Hg from the highest value 
during the test
 ► Hypertension >250 mm Hg systolic and >120 mm Hg diastolic
 – Patients with abdominal aortic aneurysms undergoing preopera-
tive assessment >200 mm Hg systolic or >110 mm Hg diastolic.
 ► Severe desaturation: SpO2 <80% (lower may be accepted in pa-
tients with known underlying lung disease or congenital heart dis-
ease if agreed with referring clinician).
 ► Loss of coordination.
 ► Mental confusion.
 ► Dizziness or faintness.
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shower may attenuate this further causing a possible 
drop in blood pressure which may lead to dizziness 
and the risk of a fall or feeling faint.
 ► To rest further in the waiting area if they wish to do so 
before leaving the department.
 ► The patient can eat and drink as usual following the 
test.
 ► The patient should also be advised that if on leaving 
the hospital they begin to experience chest pain 
that lasts more than 10 min, or if patient’s own, 
prescribed, glyceryl trinitrate (GTN) medication does 
not relieve the symptoms, they should call 111/999 or 
report to the nearest accident and emergency (A&E) 
department.
Technical comments
It is important that for all exercise tests technical infor-
mation about the test is documented. The following 
should be considered on all reports to assist with both 
data interpretation and to confirm test quality:
 ► Document the type of exercise ergometer used 
during the test.
 ► The incremental WR should be stated and also how 
long the patient exercised for.
 ► The reason for stopping the test: was the test termi-
nated by the patient (see box 7) or the clinician? 
The test will be terminated either due to maximum 
patient effort or clinical deterioration. Ascertain the 
patient’s symptoms and what they felt limited their 
ability to exercise.
Determination of maximal test
The level of effort achieved by the patient is important 
for the interpretation of an exercise test. Patients must 
reach their maximal capacity for exertion to extrapo-
late the findings at peak to their surgical risk or func-
tional capacity. Box 8 lists the criteria for determining 
if a patient’s effort during CPET could be considered 
maximal.
The RER is not a reliable indicator of maximal exer-
tion due to its variability with hyperventilation and 
erratic breathing patterns. However, if the graphical data 
presents itself normally (ie, it is not >1 during rest or 
reference exercise, it is not oscillatory as a result of an 
erratic breathing pattern), the RER may be supportive 
of maximal exertion when >1.15. We strongly recom-
mend against using a value of 1.05 to determine maximal 
exertion.67
Reference values
Reference values are a core component of a clinical exer-
cise test. Reference values provide context to measured 
values and allow for data interpretation. Compared with 
previous standard documents,9 the availability of relevant 
references values has increased considerably. However, it 
is not always clear which reference sets are appropriate. 
Takken and colleagues68 69 have published an admirable 
review of the available literature which encapsulates most 
relevant studies and sets out 14 methodological criteria 
with which to assess them. It is important to point out that 
none of the reference papers they examined achieved 
acceptability in all criteria. As such, choosing reference 
values is still a compromise and a laboratory should look 
to find the reference set which best reflects their priori-
ties from the following characteristics.
1. Contemporary—Many metabolic carts are still sold 
with some of the ‘classic’ reference values set as the 
default. These studies are generally decades old, pub-
lished in the previous century. Modern sets of refer-
ence values are continuously being published. In the 
last 5 years; more data have been published than in the 
preceding 35 years.68 Methodologies, equipment and 
technology are continuously improving. It is there-
fore imperative that current CPET practitioners move 
on to reference values published more recently (see 
table 14).
2. Geographically specific: the sample tested should be 
drawn from a similar background and geographical 
area as the laboratory’s testing population and include 
a mix of similar ethnic origins.
3. Adequate sample size: a larger sample size is favour-
able; studies with small sample sizes should be avoided.
4. Equality of sex distribution: the closer to 50/50 fe-
male/male, the better for most normal populations. 
However, there may be instances such as perioperative 
assessment for a sex- specific cancer that may be best 
served by single- sex reference values.
Box 7 Common reasons patients will stop a cardiopulmonary 
exercise testing
Test termination by patient
 ► Dyspnoea.
 ► Leg fatigue.
 ► Chest pain.
 ► Pain/physical discomfort.
 ► Dizziness.
 ► Saddle discomfort.
 ► Palpitations
Box 8 Criteria for determining if patient effort is maximal 
during cardiopulmonary exercise testing
Criteria for determining if effort is maximal
 ► Achieves a plateau in VO2 (indicating the patient has reached their 
VO2max).
 ► Heart rate reaches 90% of predicted or heart rate reserve is ≤15 
beats/min
 ► There is evidence of ventilation limitation (breathing reserve <15%, 
expiratory flow limitation, also consider significant increase in end- 
expiratory lung volume).
 ► mBorg for leg fatigue or breathlessness is ≥9/10.
 ► Peak exercise blood lactate concentration ≥8 mmol/L (if measured).
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5. Equality of age distribution: optimally, studies should 
cover paediatrics through to geriatrics, but as mini-
mum reference values should cover the upper and 
lower ages of the population being tested in the in-
tended laboratory.
6. Relevant testing parameters: having reference values 
for multiple parameters (O2pulse, AT, ΔVE/ΔVCO2, end 
test PETCO2, etc) included in the same study makes 
these values more internally consistent and is pre-
ferred to having values taken from a mix of different 
studies.
7. Statistical relevance and utility: even modern studies 
often only publish mean or median equations for the 
parameters studied. This is at odds with the trend with-
in modern medicine of using lower and upper limits 
of normal and centiles or z- scores to estimate the level 
of impairment. Precedence should be given to studies 
that provide more detailed descriptions of the values 
measured.
8. Comparable methodologies—The test protocols used 
should be consistent with that used in the intended 
laboratory and should include averaging time, appara-
tus, mode of exercise and choice of ergometer.
At the time of publishing, there is no one set of refer-
ence values which ticks all of these boxes, and so the onus 
is on individual laboratories to choose the most appro-
priate for them. In the future, the aim must be to match 
efforts such as the Global Lung Initiative70 and produce 
a set of regularly updated multicentre reference values 
that use sophisticated statistical modelling, include longi-
tudinal data, and cover children and the elderly.
We recommend the following reference values 
(table 14) for use in adults. These studies represent a good 
compromise in the areas described previously for clinical 
laboratories in the UK. It may also act as a consensus to 
provide short- term continuity between centres across the 
country if these are adopted as a default in the absence of 
better reference values.
PAEDIATRIC CONSIDERATIONS
There is high clinical value in performing CPET in paedi-
atrics in various circumstances. The non- invasive nature 
of the test makes it suitable for young children through 
to adolescents. Most children 10 years and above will be 
able to perform a technically acceptable test. However, 
this should not be a strict rule as often children as young 
as 6 will manage the test. The fundamental principles of 
CPET are the same in paediatrics as in adults. There are 
some slight modifications in the way the test is performed, 
the equipment used and the interpretation of the data. 
We detail these differences as follows based on published 
evidence and experience. Using this guidance, along 
with the recommendations already detailed, will give a 
comprehensive guide to CPET in paediatrics.
Indications
Exercise testing plays a vital role in the diagnosis and 
monitoring of paediatric cardiorespiratory disease. Phys-
ical activity is an important part in the daily life of chil-
dren and adolescents both in health and disease. CPET 
is a useful tool which can assist in excluding pathology 
in children and adolescents who are experiencing short-
ness of breath on exertion (SOBOE). Asthma is the 
most common chronic disease in childhood,71 and this 
can often be brought on or exacerbated by exercise. It is 
important to note that CPET is not a sensitive test to diag-
nose exercise- induced bronchoconstriction (EIB). If EIB 
is suspected, a constant load 6 min treadmill challenge 
test preferably in a cold, dry environment which provokes 
a ventilation of 40%–60% of MVV or 80% of predicted 
peak heart rate should be the test of choice.72 If this test 
is negative, then CPET can be used as a second- line test 
to exclude any other pathology causing the symptoms.
CPET is the gold standard for measurement of aerobic 
fitness.8 In children with cystic fibrosis (CF), aerobic 
fitness has been shown to be an independent predictor 
of mortality.73 Current European guidelines recommend 
that CPET be used routinely in children aged ≥10 years.74 
The UK CF Trust also recommends the use of exercise 
testing at annual review when clinically indicated.75 CPET 
has been shown to be a clinically useful test as part of an 
annual review procedure in children with CF.76
Children with congenital heart disease will often expe-
rience SOBOE as they go from childhood to adolescence. 
Often, they may require intervention and CPET plays an 
important role in deciding the timing of such interven-
tions. It will also help the clinician elucidate whether 
the symptoms are due to a progression of the cardiac 
disease, coexistent respiratory disease, deconditioning or 
a combination of these.77
Set-up and equipment
The setup of the CPET in children will be the same as 
that in adults described in the previous section. Equip-
ment must be available in a range of sizes to accommo-
date young children through to adolescents. Smaller 
child specific mask sizes should be used for younger 
children to ensure an adequate seal. SpO2 sensors, ECG 
electrodes and blood pressure cuffs should be available 
in paediatric sizes.
The test can be performed on a treadmill or cycle 
ergometer. The cycle ergometer is preferred for safety 
reasons as there is less chance of children injuring them-
selves. However, if they are not tall enough to reach the 
pedals adequately or if there is a specific symptom that 
occurs during running, then a treadmill protocol can 
be used. There are paediatric specific cycle ergometers 
Table 14 Recommended reference values
Adult cardiopulmonary exercise testing reference values
Cycle ergometer Gläser et al91
Treadmill Edvardsen et al92
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available. However, the main difference between these 
and a standard cycle ergometer is the child friendly 
colours and not the size. If using a standard adult ergom-
eter, there should be adjustable cranks to allow you to 
shorten them for smaller children and the option of a 
paediatric saddle, which will again help fit smaller chil-
dren onto the cycle ergometer.
Performance of the test and protocol selection
The performance of the CPET in children is very similar to 
that in adults. The five basic components described previ-
ously are the same in children—check, rest, unloaded, 
loaded and recovery phases. In terms of protocol selec-
tion, the ramp protocol is the most common and most 
suitable. The gradual increment in workload will mini-
mise effort perception and provide the gradational 
stimulus to span the intensity of the work domains. It 
is recommended that if your equipment allows it, the 
watts/min increment should be broken down into incre-
ments of 10–12 s increments. For example, a 15 W/min 
protocol will actually be increased by 2.5 W every 10 s. As 
described in the previous chapter, the ideal test duration 
is 8–12 min. The choice of ramp should be based on the 
child’s weight. The following equation requires calcula-
tion of peak VO2
78 and unloaded VO2
79 and can be used 
to calculate the optimum work increment for individual 
patients:
Male=((52.78×weight (kg)–303.4) – (5.8×weight 
(kg)+151))/103
Female=((28.5×weight (kg)–288.1) – (5.8×weight 
(kg)+151))/103
If the child has significant pulmonary or cardiac 
impairment, then the ramp calculated from the afore-
mentioned equation may be too difficult and choosing 
the ramp as folllows may be more appropriate.
Treadmill protocols are more difficult to individualise. 
However, in our experience, using a Standard Exponen-
tial Exercise Protocol (STEEP) often provides a ‘one size 
fits all’ in most children. This protocol was originally 
developed to accommodate a wide range of adult patients 
with a single protocol.80 The STEEP protocol begins at 
a low workload with 15% increments in workload each 
minute (table 15).
Some children/adolescents that are referred for CPET 
may be involved in competitive sports and this is where 
their symptoms are occurring. If the sport mainly involves 
running, then specific incremental athletic treadmill 
protocols can be used. These generally involve a small 
constant incline with increments in speed at each stage.
Staffing/supervision
Ischaemic heart disease is very rare in a young popula-
tion; therefore, exercise testing in children poses less of 
a risk to that in adults. There are no published data on 
the incidence of mortality in paediatric exercise testing, 
but this will undoubtedly be less than what is stated in the 
previous chapter for adults. In a recent American Heart 
Association statement,81 it was recommended that clin-
ical exercise tests be safely supervised by appropriately 
trained non- physician healthcare professionals. We echo 
this statement and recommend that the test be super-
vised by at least two properly trained healthcare profes-
sionals who have the experience and qualifications that 
have been detailed in the previous section. It should also 
be noted that the physician’s role as final authority for 
safety, quality and interpretation in the delivery of the 
CPET service is vital.
End test criteria
CPET is a test to a volitional maximum. Children can 
sometimes be more difficult than adults to motivate. 
However, with the correct coaching and encouragement, 
it is entirely possible. A gold standard for a maximal test 
is a plateau in the VO2. However, this is rarely seen in 
children. There are several other criteria to indicate a 
maximal effort in children during an exercise test. For 
children with normal cardiovascular function, peak heart 
rate should be within 15 beats of the predicted value.
The traditional 220 minus age equation has been shown 
to overestimate peak heart rate in children and adoles-
cents.82 Recent normal values of peak heart rate in chil-
dren and adolescents during cycle ergometry CPET show 
that boys aged 8 years have a mean of 184 beats/min with 
a small linear increase to 191 beats/min at 14 years, which 
then remains stable until 18 years old. Females aged 8 
years had a mean of 187 beats/min which had a small 
linear increase to 191 beats/min at 11 years. It then stabi-
lised at this until 14 years after which it showed a small 
linear decline to 189 at 18 years old.83 An RER, >1.1 can 
Table 15 Steep protocol
Stage (min)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Speed
(mph)
1.5 2.0 2.0 2.0 2.5 2.5 2.5 3.0 3.0 3.0 3.5 3.5 3.5 4.2 5.0
Speed
(kph)
2.4 3.2 3.2 3.2 4.0 4.0 4.0 4.8 4.8 4.8 5.6 5.6 5.6 6.7 8.0
Incline
(degrees)
0 0 1.5 3 3 5 7 7 9 11 11 13 16 16 16
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be used in most paediatric patients. However, some small 
children will not have big enough lungs to generate RERs 
as high as this during exercise; therefore, this should be 
interpreted with caution in these patients. Finally, the 
presence of respiratory compensation will indicate a near 
maximal test.
Reference values
As with any reference values, the ones which are chosen 
should best reflect the characteristics of the population 
tested and the equipment and methodology used. In a 
recent review of paediatric CPET reference values,84 it 
was concluded that current reference values are based 
on heterogeneous protocols with variable normalisa-
tion strategies and that high- quality reference values 
are still needed. The important work of Cooper and 
colleagues85–87 looking at normal values in children 
is still commonly used today. These authors looked at 
North American children and developed reference equa-
tions for VO2peak, peak O2pulse, anaerobic threshold and 
the ΔVE/ΔVCO2. They used a ramp protocol on a cycle 
ergometer in 109 children aged 6–17 years. Despite the 
widespread use of these values, they are outdated, use 
simple linear regression and only contain a small number 
of children in each age bracket.
More recently, Bongers et al83 have published reference 
values in 214 Dutch children aged 8–18 years old. They 
used the least median of squares (LMS) regression statis-
tical method, which is superior to simple regression.88 
The major disadvantage of this reference set is that they 
were in relation to sex and age only. Height and weight 
were not taken into account. Bearing in mind that the 
function of the cardiopulmonary system is heavily depen-
dent on anthropometric variables, we do not find these 
useful for most parameters.
In 2018, Blanchard et al89 published reference equa-
tions for CPET using cycle ergometry in 12–17 year 
olds. They looked at six maximal parameters including 
VO2, O2pulse, workload, ventilation, heart rate and RER. 
They also looked at a range of submaximal parameters 
including OUES, ΔVE/ΔVCO2, VO2 at the ventilatory 
threshold, ΔVO2/ΔWR and heart rate recovery after 1 
and 2 min. Polynomial regression equations were used, 
taking into account sex, age, height and weight. Another 
major benefit is that they allow for the generation of Z 
scores. They found that CPET parameters had a strong 
correlation with fat- free mass but a weak correlation with 
fat mass. This led to development of prediction equations 
that use ideal body weight if the subject has a high body 
mass index.
Currently, we would recommend using the Blanchard 
predicted set when the patient is aged 12–17. If the 
patient is <12 years old, then the Cooper values are 
recommended. However, care should be taken when 
interpreting these values if the patient is overweight. If 
testing is performed on a treadmill, then the predicted 
VO2 from cycle ergometry should be increased by 11% 
to take into account the different exercise modality.31
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